GlassScriptPhysician profile
Timothy C Epting
NPI 1275796765
$55,565.90
in general payments reported to CMS, 2019-2025
23 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,883 · 2020: $2,769 · 2021: $8,285 · 2022: $2,140 · 2023: $9,851 · 2024: $13K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $8,279 · Consulting Fee: $5,325 · Travel and Lodging: $3,000 · Long Term Medical Supply Or Device Loan: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,825.00 |
| Food and Beverage | $8,278.74 |
| Consulting Fee | $5,325.00 |
| Travel and Lodging | $3,000.09 |
| Long Term Medical Supply Or Device Loan | $1,059.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $34,090.61 | 2019-2025 | Distal Extremities Instruments Foot & Ankle Mis Disposables |
| Stryker Corporation | $8,206.15 | 2019-2025 | Infinity Adaptis, Actishield, Inbone |
| Coastal Medical Technologies LLC | $2,590.02 | 2023-2025 | |
| Mvp Orthopedics INC | $2,032.03 | 2019-2022 | |
| Wright Medical Technology, INC. | $1,892.83 | 2019-2020 | |
| Axogen | $1,575.00 | 2025 | Axoguard Ha+ Nerve Protector |
| Reel Surgical, INC. | $1,254.98 | 2021-2023 | |
| Integra Lifesciences Corporation | $1,059.47 | 2025 | Amnioexcel Plus, Micromatrix |
| Trice Medical, INC. | $582.74 | 2021-2025 | |
| Novastep INC. | $536.14 | 2022 | |
| Innovation Technologies INC | $420.20 | 2021-2024 | Irrisept |
| Zimmer Biomet Holdings, INC. | $250.55 | 2024 | Affixus |
| Restor3d, INC. | $182.36 | 2023 | |
| Linvatec Corporation | $150.01 | 2023 | 5ms, Quantum, Neospan Superelastic Compression Staple W/Instruments, Size 10x10x10 |
| Medshape, INC. | $149.17 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $144.39 | 2025 | Cerament G, Ceramentbone Void Filler |
| Medline Industries LP | $139.53 | 2023 | |
| Paragon 28, INC. | $130.98 | 2024 | Total Talus |
| Smith+Nephew, INC. | $101.94 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System |
| Anika Therapeutics, INC. | $21.11 | 2021 | |
| Medtronic, INC. | $20.52 | 2024 | Plasmablade(Tm) |
| Sanara Medtech INC. | $19.77 | 2023 | Celleraterx |
| Horizon Therapeutics Plc | $15.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Epting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.